UK EC ruling
This article was originally published in The Tan Sheet
UK judge rules emergency contraception can continue to be lawfully supplied by a physician or over-the-counter in pharmacies, Department of Health announces April 18. Society for Protection of the Unborn Child applied for Judicial Review of ECs, alleging they cause abortions and should not be legally administered. The case was heard Feb. 12-14; the judge found SPUC's legal argument to be "erroneous" and dismissed application. Case hinged on definition of when pregnancy begins; established medical view in the UK is that pregnancy begins at implantation and not when an egg is fertilized. EC works before implantation and cannot take effect if taken post implantation...
You may also be interested in...
Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.
Biopharma is working on a reputation renaissance as the public looks to industry for treatments and vaccines for the COVID-19 epidemic and drug pricing concerns take a back seat.